Quick answer: A published study in healthy adult Beagles found that dietary bovine lactoferrin changed some immune measures and tended to change some fecal bacterial populations. This suggests biological activity, but it does not prove that a retail lactoferrin chew treats digestive disease or produces the same microbiome outcome.
What did the dog study examine?
Eighteen Beagle dogs were used in a controlled feeding study. Dogs received diets containing different levels of bovine lactoferrin for a defined period, and researchers measured immune-cell responses and fecal bacterial populations.
What did researchers report?
Supplementation altered some cellular immune measures. Dogs receiving bovine lactoferrin also tended to have lower fecal concentrations of some bacterial groups, while other measures were unchanged.
Why this is not a treatment claim
- The study involved healthy research dogs.
- The lactoferrin was delivered within controlled diets.
- Microbiome-related measures are not the same as proving relief of diarrhea or another disease.
- A retail chew may use a different dose and formulation.
How to use this evidence responsibly
Use the research to understand why lactoferrin is biologically interesting, not to predict a guaranteed outcome in an individual pet.
Related guides
Source
Written by the PetVibess Editorial Team. General educational information only; not veterinary treatment advice. Updated October 9, 2026.